| Financial Year |
March 31 2023 |
| Monetary Funds |
1,776,519,404.67 |
| Held-for-trading Financial Assets |
20,100,201.03 |
| Notes Receivable |
8,000,000.00 |
| Accounts Receivable |
400,035,475.65 |
| Advances to Suppliers |
669,627,171.20 |
| Other Receivables |
345,187,444.66 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,317,936,854.92 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
129,602,198.35 |
| Total Current Assets |
6,699,388,282.13 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
60,064,113.08 |
| Investment Properties |
-- |
| Fixed Assetes |
8,448,536,457.35 |
| Under-construction Projects |
749,955,024.88 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
631,921,633.47 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
543,043,950.84 |
| R&D expenses |
-- |
| Goodwill |
317,001,999.37 |
| Long-Term Deferred and Prepaid Expenses |
21,027,966.07 |
| Deferred Income Tax Assets |
60,542,986.20 |
| Other Non-Current Assets |
68,457,811.44 |
| Sub-Total of Non-Current Assets |
11,610,194,644.60 |
| Total Assets |
18,309,582,926.73 |
| Short-Term Loans |
1,399,147,548.39 |
| Trading Financial liabilities |
-- |
| Notes Payable |
81,730,400.00 |
| Accounts Payable |
1,533,123,909.80 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
171,708,427.32 |
| Taxes Payable |
54,138,773.54 |
| Interest Payable |
-- |
| Dividend Payable |
18,000,000.00 |
| Other payables |
931,092,802.55 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,896,891,788.76 |
| Other Current Liabilities |
7,357,300.49 |
| Sub-Total of Current Liabilities |
6,399,575,513.75 |
| Long-term Loans |
3,500,232,613.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
726,910,678.76 |
| Special Payable |
-- |
| Estimatied Liabilities |
713,241.96 |
| Deferred Income Tax Liabilities |
16,111,439.32 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,738,717,833.56 |
| Total Liabilities |
11,138,293,347.31 |
| Paid-In Capital(Or Share Stock) |
1,387,596,848.00 |
| Capital Surplus |
4,814,607,989.31 |
| Surplus Reserve |
436,444,947.81 |
| LESS:Treasury Stock |
100,956,510.04 |
| Undistributed Profits |
-48,657,940.46 |
| Minority Stockholder's Interest |
652,117,376.30 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,519,172,203.12 |
| Owner's Equity（Stockholder's Equity） |
7,171,289,579.42 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
18,309,582,926.73 |
